Change from New Business R&D Expenses to Company-Wide Expense Allocation
First written in FY2023-Q1. . Latest entry: FY2026.
7 other companies' latest entry also says "Other".
- FY2026Update to annual allocation impactAnnual report
「The adjustment to segment profit or loss includes ¥1,360 million in company-wide expenses not allocated to the individual reporting segments. The company-wide expenses consist of R&D expenses and other costs related to new businesses that are not attributable to the reporting segments.」
The company continued allocating R&D expenses and other costs related to new businesses as company-wide expenses and updated the adjustment to segment profit for the current fiscal year to ¥1,360 million. - FY2026-H1Update to first-half company-wide expense allocationAnnual report
「The adjustment to segment profit or loss includes ¥678 million in company-wide expenses not allocated to the individual reporting segments. The company-wide expenses consist of R&D expenses and other costs related to new businesses that are not attributable to the reporting segments.」
The company continued treating R&D expenses and other costs related to new businesses as company-wide expenses and disclosed the adjustment to segment profit for the current interim consolidated accounting period as ¥678 million. - FY2025Update to annual allocation impactAnnual report
「The adjustment to segment profit for the current consolidated fiscal year includes ¥1,121 million in company-wide expenses not allocated to the individual reporting segments. The company-wide expenses consist of R&D expenses and other costs related to new businesses that are not attributable to the reporting segments.」
The company continued allocating R&D expenses and other costs related to new businesses as company-wide expenses and updated the annual adjustment to segment profit to ¥1,121 million. - FY2025-H1Update to first-half company-wide expense allocationAnnual report
「The adjustment to segment profit includes ¥543 million in company-wide expenses not allocated to the individual reporting segments. The company-wide expenses are R&D expenses related to new businesses that are not attributable to the reporting segments.」
The company continued treating R&D expenses related to new businesses as company-wide expenses and disclosed the adjustment to segment profit for the current interim consolidated accounting period as ¥543 million. - FY2024Update to annual allocation impactAnnual report
「The adjustment to segment profit for the current consolidated fiscal year includes ¥1,250 million in company-wide expenses not allocated to the individual reporting segments. The company-wide expenses consist of R&D expenses and other costs related to new businesses that are not attributable to the reporting segments.」
The company continued allocating R&D expenses and other costs related to new businesses as company-wide expenses and disclosed the full-year adjustment as ¥1,250 million. - FY2024-Q3Update to third-quarter allocation impactAnnual report
「The adjustment to segment profit or loss includes ¥925 million in company-wide expenses not allocated to the individual reporting segments. The company-wide expenses consist of R&D expenses and other costs related to new businesses that are not attributable to the reporting segments.」
The company continued treating R&D expenses and other costs related to new businesses as company-wide expenses and disclosed the third-quarter cumulative adjustment to segment profit as ¥925 million. - FY2024-Q2Update to first-half allocation impactAnnual report
「The adjustment to segment profit includes ¥661 million in company-wide expenses not allocated to the individual reporting segments. The company-wide expenses are R&D expenses related to new businesses that are not attributable to the reporting segments.」
The company continued treating R&D expenses related to new businesses as company-wide expenses and disclosed the company-wide expenses and adjustment to segment profit for the first half as ¥661 million. - FY2024-Q1Update to first-quarter allocation impactAnnual report
「The adjustment to segment profit includes ¥348 million in company-wide expenses not allocated to the individual reporting segments. The company-wide expenses are R&D expenses related to new businesses that are not attributable to the reporting segments.」
The company continued treating R&D expenses related to new businesses as company-wide expenses and disclosed the first-quarter adjustment to segment profit as ¥348 million. - FY2023Update to annual allocation impactAnnual report
「As a result, compared with the previous calculation method, segment profit for the current consolidated fiscal year increased by ¥328 million in the Life and Health-Related Industries, ¥367 million in the Petroleum and Transportation-Related Industries, ¥362 million in the Plastic and Fiber-Related Industries, ¥266 million in the Information, Electrical and Electronic-Related Industries, and ¥178 million in the Environment and Housing Equipment-Related Industries and other businesses, while the adjustment to segment profit decreased by ¥1,501 million.」
The company continued allocating R&D expenses for new businesses to company-wide expenses and disclosed the impact on full-year segment profit and the adjustment. - FY2023-Q3Update to allocation impactAnnual report
「As a result, compared with the previous calculation method, segment profit for the first nine months of the current consolidated fiscal year increased by ¥252 million in the Life and Health-Related Industries, ¥272 million in the Petroleum and Transportation-Related Industries, ¥273 million in the Plastic and Fiber-Related Industries, ¥205 million in the Information, Electrical and Electronic-Related Industries, and ¥137 million in the Environment and Housing Equipment-Related Industries and other businesses, while the adjustment to segment profit decreased by ¥1,141 million.」
The company continued allocating R&D expenses for new businesses to company-wide expenses and disclosed the impact on segment profit for the first nine months and the ¥1,141 million decrease in the adjustment. - FY2023-Q2Update to allocation impactAnnual report
「As a result, compared with the previous calculation method, segment profit for the first half of the current consolidated fiscal year increased by ¥166 million in the Life and Health-Related Industries, ¥184 million in the Petroleum and Transportation-Related Industries, ¥186 million in the Plastic and Fiber-Related Industries, ¥144 million in the Information, Electrical and Electronic-Related Industries, and ¥93 million in the Environment and Housing Equipment-Related Industries and other businesses, while the adjustment to segment profit decreased by ¥775 million.」
The company continued allocating R&D expenses for new businesses to company-wide expenses and disclosed the impact on segment profit for the first half and the ¥775 million decrease in the adjustment. - FY2023-Q1First statedAnnual report
「From the first quarter of the current consolidated cumulative period, R&D expenses related to new businesses, which had previously been allocated to each reporting segment, have been classified as company-wide expenses in order to better assess the performance of each reporting segment.」
The company changed the allocation method for R&D expenses related to new businesses, allocating them from the individual reporting segments to company-wide expenses, and reviewed how segment performance is assessed. As a result of the change, segment profit increased from ¥81 million to ¥87 million and by ¥48 million, while the adjustment to segment profit decreased by ¥371 million.